PD-1 blockage as consolidation therapy after autologous stem cell transplant in patients with T-cell non-Hodgkin’s lymphoma shows improvements in progression-free survival
No. 9 Medical Innovation for 2020: PARP Inhibitors for Maintenance Therapy in Ovarian Cancer
PARP inhibitors for maintenance therapy in ovarian cancer will be the No. 9 most influential medical innovation for 2020, predict experts at Cleveland Clinic.